Michael Gelband’s Exact Sciences EXAS Stock Holding History

Michael Gelband’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-39,600	Closed	-$4.15M	–	1709
2026 Q1	$4.15M	Buy	39,600 +5,700	+17%	+$587K	0.03%	499
2025 Q4	$3.44M	Buy	+33,900	New	+$2.72M	0.03%	599

Other funds holding EXAS

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Michael Gelband's EXAS Position: Q1 2026 in Review

Michael Gelband sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 266,329 shares — an estimated $27.4M sold.

Michael Gelband first reported a position in EXAS in Q1 2019 and held it in 19 quarters. The position peaked at $27M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Michael Gelband reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Michael Gelband sold 266,329 Exact Sciences shares in Q1 2026, an estimated $27.4M.
Michael Gelband first reported a position in Exact Sciences in Q1 2019 and held it in 19 quarters.
Michael Gelband's Exact Sciences position peaked at $27M in Q4 2025.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.